Wilma Kiander

University of Helsinki — Finland

Medicine · Health Sciences

6h-index176citations14works1.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Drug Transport and Resistance Mechanisms(11), Pharmacogenetics and Drug Metabolism(3), Lipoproteins and Cardiovascular Health(3), Cancer, Lipids, and Metabolism(3), HIV/AIDS drug development and treatment(2)

Publications14 total

Corrigendum to “Effects of nonsense genetic variants on OATP1B1 expression and transport activity in vitro” [European Journal of Pharmaceutical Sciences 215 (2025) 107322]
European Journal of Pharmaceutical Sciences·2025Open Access
Effects of nonsense genetic variants on OATP1B1 expression and transport activity in vitro
European Journal of Pharmaceutical Sciences·2025Open Access
Enhancing cholesterol efflux and ABCA1 expression in macrophages using anti-MIR33 and LXR agonists loaded in HDL-mimicking nanodiscs
Atherosclerosis·2025Open Access
In vitro characterization of SLCO2B1 genetic variants
Journal of Pharmaceutical Sciences·2025· 3 citedOpen Access
Comparative uptake of statins by hepatic organic anion transporting polypeptides
European Journal of Pharmaceutical Sciences·2025· 6 citedOpen Access
Induction of cholesterol efflux and ABCA1 activity in macrophages using LXR agonists packed in HDL mimetic nanodiscs
Atherosclerosis·2024
Preincubation-dependent inhibition of organic anion transporting polypeptide 2B1
European Journal of Pharmaceutical Sciences·2024· 4 citedOpen Access
Functional Characterization of Six <i>SLCO1B1</i> (OATP1B1) Variants Observed in Finnish Individuals with a Psychotic Disorder
Molecular Pharmaceutics·2023· 1 citedOpen Access
Rhabdomyolysis during concomitant ticagrelor and rosuvastatin: A breast cancer resistance protein‐mediated drug interaction?
British Journal of Clinical Pharmacology·2023· 14 citedOpen Access
Functional characterization of six <i>SLCO1B1</i> (OATP1B1) variants observed in Finnish individuals with a psychotic disorder
2022Open Access
Functional in vitro characterization of SLCO1B1 variants and simulation of the clinical pharmacokinetic impact of impaired OATP1B1 function.
European Journal of Pharmaceutical Sciences·2022· 16 citedOpen Access
The Role of Uptake and Efflux Transporters in the Disposition of Glucuronide and Sulfate Conjugates
Frontiers in Pharmacology·2022· 87 citedOpen Access
The Effect of Single Nucleotide Variations in the Transmembrane Domain of OATP1B1 on in vitro Functionality
Pharmaceutical Research·2021· 10 citedOpen Access
Enantiospecific Pharmacogenomics of Fluvastatin
Clinical Pharmacology & Therapeutics·2019· 35 citedOpen Access

Frequent Co-authors

Heidi Kidron(14), Mikko Niemi(9), Mikko Neuvonen(5), Kati‐Sisko Vellonen(5), Alli Sinokki(4), Noora Sjöstedt(4), Mikko Gynther(4), Seppo Auriola(3), Kristiina M. Huttunen(3), Feng Deng(2), Kati-Sisko Vellonen(2), Seppo Auriola(2), Madhushree Bhattacharya(2), Annika Miinalainen(2), Katja Häkkinen(2), Markku Lähteenvuo(2), Lea Urpa(2), Jonne Lintunen(2), Minna Torniainen‐Holm(2), Kaisla Lahdensuo(2)